Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from the company’s still ongoing study. A week ago, competitor Pfizer Inc. announced its COVID-19 vaccine appeared similarly significant, news that puts both companies on track to seek permission within weeks for emergency use in the U.S.